| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |